Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
The Impact of Treatment Recommendation By Leukemia Artificial Intelligence Program (LEAP) on Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
25 února, 2021 5:27 pmProgram: Oral and Poster Abstracts Session: 632. Chronic Myeloid Leukemia: Therapy: Poster I Hematology Disease Topics & Pathways:...
RNA Splicing Defects in Cancer-Linked Genes Indicate Mutation or Focal Gene Deletion and Are Associated with TKI Resistance in CML
25 února, 2021 5:25 pmProgram: Oral and Poster Abstracts Type: Oral Session: 632. Chronic Myeloid Leukemia: Therapy: Response Monitoring and Prognosis ...
Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database
25 února, 2021 5:17 pmProgram: Oral and Poster Abstracts Type: Oral Session: 632. Chronic Myeloid Leukemia: Therapy: Clinical Trials and Outcomes ...
Chronická myelocytová leukémia – novinky z výročnej konferencie ASH® 2019
25 února, 2021 5:11 pmŠesťdesiata prvá výročná konferencia Americkej hematologickej spoločnosti (posledná v tomto desaťročí) – v skratke ASH® 2019 – sa konala od 7. do 10. 12....
Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3-ITD-Negative Patients: ECOG-ACRIN (E-A) E2906 Randomized Study
25 února, 2021 5:04 pmProgram: Oral and Poster Abstracts Type: Oral Session: 615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Induction...
Response to Sorafenib in FLT3/ITD AML Is Depedent on Co-Occurring Mutational Profile
25 února, 2021 4:56 pmProgram: Oral and Poster Abstracts Type: Oral Session: 615. Acute Myeloid Leukemia: Commercially Available Therapy, Excluding Transplantation: Induction...
Patterns of Care and Clinical Outcomes with 7 + 3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based Study
25 února, 2021 4:47 pmProgram: Oral and Poster Abstracts Type: Oral Session: 615. Acute Myeloid Leukemia: Commercially Available Therapy, Excluding Transplantation: Induction...
leukemie
25 února, 2021 4:40 pmKonference Americké hematologické společnosti ASH® 2019, jež se konala v Orlandu na Floridě, představila algoritmus terapie akutní myeloidní leukemie (AML). V oblastech molekulární...
Rozanolixizumab, an Anti-FcRn Antibody: Final Results from a Phase II, Multiple-Dose Study in Patients with Primary Immune Thrombocytopenia
25 února, 2021 4:36 pmProgram: Oral and Poster Abstracts Type: Oral Session: 311. Disorders of Platelet Number or Function: Advances in ITP...
Phase II Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia
25 února, 2021 4:29 pmProgram: Oral and Poster Abstracts Type: Oral Session: 311. Disorders of Platelet Number or Function: Advances in ITP...